Skip to main content

Peer Review reports

From: Radotinib attenuates TGFβ -mediated pulmonary fibrosis in vitro and in vivo: exploring the potential of drug repurposing

Original Submission
11 Apr 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
8 May 2022 Reviewed Reviewer Report
30 May 2022 Reviewed Reviewer Report
14 Jun 2022 Author responded Author comments - Kang Pa Lee
Resubmission - Version 3
14 Jun 2022 Submitted Manuscript version 3
24 Jun 2022 Author responded Author comments - Kang Pa Lee
Resubmission - Version 4
24 Jun 2022 Submitted Manuscript version 4
20 Jul 2022 Reviewed Reviewer Report
21 Sep 2022 Author responded Author comments - Kang Pa Lee
Resubmission - Version 5
21 Sep 2022 Submitted Manuscript version 5
25 Sep 2022 Author responded Author comments - Kang Pa Lee
Resubmission - Version 6
25 Sep 2022 Submitted Manuscript version 6
27 Sep 2022 Author responded Author comments - Kang Pa Lee
Resubmission - Version 7
27 Sep 2022 Submitted Manuscript version 7
28 Oct 2022 Reviewed Reviewer Report
16 Nov 2022 Author responded Author comments - Kang Pa Lee
Resubmission - Version 8
16 Nov 2022 Submitted Manuscript version 8
20 Nov 2022 Author responded Author comments - Kang Pa Lee
Resubmission - Version 9
20 Nov 2022 Submitted Manuscript version 9
21 Nov 2022 Author responded Author comments - Kang Pa Lee
Resubmission - Version 10
21 Nov 2022 Submitted Manuscript version 10
Publishing
29 Nov 2022 Editorially accepted
15 Dec 2022 Article published 10.1186/s40360-022-00634-x

You can find further information about peer review here.

Back to article page